Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Exchange Rate Effect (2019 - 2025)

Historic Exchange Rate Effect for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $355000.0.

  • Pulmonx's Exchange Rate Effect rose 39831.93% to $355000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$140000.0, marking a year-over-year increase of 5718.65%. This contributed to the annual value of $76000.0 for FY2024, which is 12352.94% up from last year.
  • Latest data reveals that Pulmonx reported Exchange Rate Effect of $355000.0 as of Q3 2025, which was up 39831.93% from -$583000.0 recorded in Q2 2025.
  • Pulmonx's Exchange Rate Effect's 5-year high stood at $355000.0 during Q3 2025, with a 5-year trough of -$583000.0 in Q2 2025.
  • Moreover, its 5-year median value for Exchange Rate Effect was $21000.0 (2022), whereas its average is $1473.7.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 430000.0% in 2022, then tumbled by 116739.13% in 2025.
  • Pulmonx's Exchange Rate Effect (Quarter) stood at $90000.0 in 2021, then plummeted by 322.22% to -$200000.0 in 2022, then fell by 5.0% to -$210000.0 in 2023, then skyrocketed by 191.9% to $193000.0 in 2024, then surged by 83.94% to $355000.0 in 2025.
  • Its Exchange Rate Effect was $355000.0 in Q3 2025, compared to -$583000.0 in Q2 2025 and -$105000.0 in Q1 2025.